Novartis India Limited reported earnings results for the fourth quarter and full year ended March 31, 2025. For the fourth quarter, the company reported sales was INR 838.8 million compared to INR 811.7 million a year ago. Revenue was INR 945.1 million compared to INR 915.9 million a year ago. Net income was INR 293 million compared to INR 146.8 million a year ago. Basic earnings per share from continuing operations was INR 11.87 compared to INR 5.95 a year ago. Diluted earnings per share from continuing operations was INR 11.87 compared to INR 5.95 a year ago.
For the full year, sales was INR 3,562.7 million compared to INR 3,350.7 million a year ago. Revenue was INR 3,982.3 million compared to INR 3,967.5 million a year ago. Net income was INR 1,009 million compared to INR 851.9 million a year ago. Basic earnings per share from continuing operations was INR 40.87 compared to INR 34.5 a year ago. Diluted earnings per share from continuing operations was INR 40.87 compared to INR 34.5 a year ago.